V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10005908 | 10003759 | 1.7 | 47.7 | Adjuvant (A) | 2016-01-28 | 2016-02-02 | FLUOROURACIL + IRINOTECAN | 02 | N | 10295139 | IRINOTECAN + MDG |
| 10005909 | 10003761 | 1.6 | 57 | Palliative (P) | 2018-08-27 | 2018-09-02 | Docetaxel | N | N | 10295195 | DOCETAXEL |
| 10005910 | 10003762 | 1.75 | 101.6 | Adjuvant (A) | 2018-02-17 | 2018-02-27 | Irinotecan + Modified De Gramont | N | N | 10295204 | IRINOTECAN + MDG |
| 10005911 | 10003763 | 1.84 | 91.8 | Curative (C) | 2014-07-01 | 2014-11-18 | Paclitaxel 7 day | N | N | 10295204 | PACLITAXEL |
| 10005912 | 10003763 | 1.65 | 53.1 | Palliative (P) | 2017-08-15 | 2017-12-26 | Oxaliplatin + Modified de Gramont | N | N | 10295204 | OXALIPLATIN + MDG |
| 10005913 | 10007017 | 1.68 | null | Adjuvant (A) | 2016-03-23 | 2016-06-09 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 10295539 | RITUXIMAB |
| 10005914 | 10007017 | 1.7 | 82.4 | Palliative (P) | 2017-12-19 | 2017-12-19 | Irinotecan + Modified De Gramont | 02 | null | 10295539 | IRINOTECAN + MDG |
| 10005915 | 10008907 | 1.64 | 79 | Adjuvant (A) | 2018-07-15 | 2018-07-29 | CHOP R - 21 days | N | N | 10295622 | CHOP R |
| 10005916 | 10003765 | 1.68 | 54.7 | Palliative (P) | 2018-09-08 | 2018-09-11 | CHOP R | 02 | N | 10295759 | CHOP R |
| 10005917 | 10003765 | 1.8 | 49.9 | Adjuvant (A) | 2016-05-13 | 2016-11-04 | PEMBROLIZUMAB | 2 | N | 10295759 | PEMBROLIZUMAB |
| 10005918 | 10003766 | 1.75 | 70.1 | Palliative (P) | 2018-01-06 | 2018-01-08 | Docetaxel 100mg/m2 (21 day) | 02 | N | 10296382 | DOCETAXEL |
| 10005919 | 10003767 | 1.65 | 93 | Palliative (P) | 2018-02-12 | 2018-02-23 | PEMBROLIZUMAB | 02 | N | 10296436 | PEMBROLIZUMAB |
| 10005920 | 10003768 | 1.83 | 72.7 | Palliative (P) | 2017-07-06 | 2017-07-06 | Rituximab | 2 | N | 10296493 | RITUXIMAB |
| 10005921 | 10003768 | 1.67 | 60.6 | Adjuvant (A) | 2019-02-03 | 2019-02-17 | TRASTUZUMAB | N | N | 10296493 | TRASTUZUMAB |
| 10005922 | 10003769 | 1.6 | 104 | Neo-adjuvant (N) | 2019-02-17 | 2019-03-09 | TRASTUZUMAB | 02 | N | 10296834 | TRASTUZUMAB |
| 10005923 | 10003769 | 1.62 | 0 | Not known (9) | null | 2015-01-22 | Rituximab | N | N | 10296834 | RITUXIMAB |
| 10005924 | 10003770 | 1.74 | 74 | Adjuvant (A) | 2018-05-30 | 2018-05-31 | PEMBROLIZUMAB | N | N | 10297048 | PEMBROLIZUMAB |
| 10005925 | 10003771 | 1.78 | null | Palliative (P) | 2015-07-27 | 2015-07-29 | Rituximab | N | null | 10297372 | RITUXIMAB |
| 10005926 | 10003772 | 1.74 | null | Radical (R) | 2015-05-31 | 2016-05-01 | Docetaxel | N | N | 10297372 | DOCETAXEL |
| 10005927 | 10003773 | 1.64 | 72 | Palliative (P) | 2016-06-06 | 2016-06-06 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 10297722 | RITUXIMAB |
| 10005928 | 10003773 | 1.63 | 85 | Adjuvant (A) | 2015-03-19 | 2015-03-20 | Rituximab (Maintenance) | 02 | N | 10297722 | RITUXIMAB |
| 10005929 | 10003774 | 1.57 | 66 | Palliative (P) | null | 2016-09-06 | Capecitabine + Oxaliplatin 21day | N | N | 10298003 | CAPECITABINE + OXALIPLATIN |
| 10005930 | 10003774 | 1.75 | 61.4 | Palliative (P) | 2018-02-26 | 2018-03-20 | TRASTUZUMAB | N | N | 10298003 | TRASTUZUMAB |
| 10005931 | 10008353 | 1.65 | 69.4 | Palliative (P) | 2014-06-23 | 2014-08-10 | CHOP R - 21 days | N | N | 10298102 | CHOP R |
| 10005932 | 10003775 | 1.7 | 78.2 | Palliative (P) | null | 2014-02-23 | Capecitabine + Oxaliplatin 14day | null | null | 10298144 | CAPECITABINE + OXALIPLATIN |
| 10005933 | 10003778 | 1.75 | 67.2 | Not known (9) | 2018-04-13 | 2018-04-13 | Rituximab (Maintenance) | 02 | N | 10298259 | RITUXIMAB |
| 10005934 | 10003780 | null | 81.6 | Palliative (P) | 2016-08-19 | 2016-08-26 | CHOP R | N | N | 10298312 | CHOP R |
| 10005935 | 10003782 | 1.77 | 110.2 | Curative (C) | 2018-08-02 | 2018-08-04 | Docetaxel 100mg/m2 (21 day) | N | N | 10298377 | DOCETAXEL |
| 10005936 | 10003782 | 0 | 78.9 | Palliative (P) | 2016-07-23 | 2016-08-05 | TRASTUZUMAB | N | Y | 10298377 | TRASTUZUMAB |
| 10005937 | 10003783 | 1.68 | 70.8 | Palliative (P) | 2018-02-06 | 2018-04-11 | Capecitabine + Oxaliplatin 21day | N | N | 10298421 | CAPECITABINE + OXALIPLATIN |
| 10005938 | 10003783 | 1.65 | 78.7 | Adjuvant (A) | 2017-01-02 | 2018-01-02 | Docetaxel | N | N | 10298421 | DOCETAXEL |
| 10005939 | 10003784 | 1.6 | 59 | Palliative (P) | 2018-05-01 | 2018-05-15 | PEMBROLIZUMAB | N | N | 10299056 | PEMBROLIZUMAB |
| 10005940 | 10007029 | 1.7 | 99.5 | Adjuvant (A) | 2017-12-08 | 2017-12-08 | Trastuzumab Subcutaneous | N | N | 10299179 | TRASTUZUMAB |
| 10005941 | 10003786 | null | 58.1 | Radical (R) | 2018-12-15 | 2018-12-16 | Trastuzumab Subcutaneous | N | N | 10299225 | TRASTUZUMAB |
| 10005942 | 10007030 | 1.7 | 74.7 | Palliative (P) | 2014-08-25 | 2014-12-19 | Rituximab (Maintenance) | null | N | 10299410 | RITUXIMAB |
| 10005943 | 10007030 | 1.75 | null | Palliative (P) | 2017-04-27 | 2018-04-21 | CAPECITABINE + OXALIPLATIN | 2 | null | 10299410 | CAPECITABINE + OXALIPLATIN |
| 10005944 | 10003790 | 1.66 | 62.7 | Palliative (P) | 2016-04-27 | 2016-05-22 | Irinotecan + Modified De Gramont | N | N | 10300124 | IRINOTECAN + MDG |
| 10005945 | 10003791 | 0 | 62.4 | Adjuvant (A) | 2017-08-16 | 2017-11-09 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 10300330 | RITUXIMAB |
| 10005946 | 10007031 | 1.82 | null | Palliative (P) | 2015-02-14 | 2016-08-28 | TRASTUZUMAB | 02 | N | 10300602 | TRASTUZUMAB |
| 10005947 | 10003792 | 1.85 | 80.7 | Adjuvant (A) | 2017-03-08 | 2017-04-05 | CHOP R - 21 days | N | N | 10300707 | CHOP R |
| 10005948 | 10003793 | 1.56 | 48.4 | Curative (C) | 2018-01-04 | 2018-04-05 | Docetaxel 75mg/m2 (21 day) | N | N | 10300948 | DOCETAXEL |
| 10005949 | 10007032 | 1.94 | 73.6 | Palliative (P) | 2018-10-30 | 2018-11-10 | FLUOROURACIL + IRINOTECAN | 02 | N | 10300981 | IRINOTECAN + MDG |
| 10005950 | 10003794 | 1.83 | 73.7 | Adjuvant (A) | 2016-12-31 | 2017-06-24 | CHOP R - 21 days | N | N | 10301086 | CHOP R |
| 10005951 | 10003795 | 1.68 | 80.6 | Adjuvant (A) | 2015-11-07 | 2015-12-01 | TRASTUZUMAB | N | N | 10301264 | TRASTUZUMAB |
| 10005952 | 10003796 | 1.78 | 68.4 | Adjuvant (A) | 2016-12-23 | 2017-01-17 | Docetaxel | N | N | 10301264 | DOCETAXEL |
| 10005953 | 10003797 | 1.57 | 72.4 | Palliative (P) | 2018-05-29 | 2018-05-29 | PACLITAXEL | N | N | 10301627 | PACLITAXEL |
| 10005954 | 10003797 | 1.65 | null | Palliative (P) | 2015-09-22 | 2015-10-21 | CHOP R - 21 days | 02 | N | 10301627 | CHOP R |
| 10005955 | 10003798 | 1.71 | 63.6 | Curative (C) | 2013-08-11 | 2013-08-23 | Trastuzumab Subcutaneous | N | N | 10301901 | TRASTUZUMAB |
| 10005956 | 10003799 | 1.82 | 72.6 | Palliative (P) | 2015-12-09 | 2016-04-23 | Docetaxel | N | N | 10302149 | DOCETAXEL |
| 10005957 | 10003799 | 1.74 | 87 | Palliative (P) | 2018-10-10 | 2018-10-31 | Trastuzumab 21 day maintenance | null | Y | 10302149 | TRASTUZUMAB |